Keywords: bristol-myers, squibb, buys, dupont, pharma, billion, after
Bristol-Myers Squibb buys DuPont Pharma for $7.8 billion
Article | 11 June 2001
After a week of speculation, Bristol-Myers Squibb has signed anagreement with DuPont to acquire the latter's pharmaceutical business for $7.8 billion ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Elan puts up formal "for sale" notice
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
